A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Events
  • Panel discussion: The Evolving Needs of Women’s Sexual and Repr...
Panel discussion - Event date: 17 Mar 2022
Share

The Evolving Needs of Women’s Sexual and Reproductive Health

Access to Medicine Foundation CEO Jayasree K. Iyer is set to speak at an event in London on the morning of Thursday 17 March 2022, addressing the topic: “A Period of Change: The Evolving Needs of Women’s Sexual and Reproductive Health”.

Explore further

Feature

2021 Ranking

Pharmaceutical companies continue to inch forward in addressing access to medicine in low- and middle-income countries, finds the 2021 Access to Medicine Index. Pfizer moves into the top five. GSK retains its number one position, yet only slightly ahead of Novartis.

News

Three ways to fix healthcare supply chains and improve global health security

The global supply of essential medicines and vaccines is currently highly vulnerable to disruption. To address this urgent problem, the Access to Medicine Foundation brought together leading experts from industry, global health and governments to identify solutions and mindset shifts in supply chain management and procurement.
Event

How investors can strengthen health equity: lessons learned from the pandemic

Damiano de Felice, Director of Strategy for the Access to Medicine Foundation, will join a webinar hosted by the Principles for Responsible Investment (PRI) to discuss lessons learned from the COVID-19 pandemic and investor-driven solutions needed to ensure health equity and universal access to healthcare.

Get in touch

Back to top |